O	0	12	Relationship	Relationship	NN	B-NP
O	13	16	and	and	CC	I-NP
O	17	27	prognostic	prognostic	JJ	I-NP
O	28	40	significance	significance	NN	I-NP
O	41	43	of	of	IN	B-PP
O	44	49	SPARC	SPARC	NN	B-NP
O	50	53	and	and	CC	I-NP
O	54	58	VEGF	VEGF	NN	I-NP
O	59	66	protein	protein	NN	I-NP
O	67	77	expression	expression	NN	I-NP
O	78	80	in	in	IN	B-PP
B-Cancer	81	86	colon	colon	NN	B-NP
I-Cancer	87	93	cancer	cancer	NN	I-NP
O	93	94	.	.	.	O

O	96	106	BACKGROUND	BACKGROUND	NN	B-NP
O	106	107	:	:	:	O
O	108	113	SPARC	SPARC	NN	B-NP
O	114	115	(	(	(	O
O	115	123	secreted	secrete	VBN	B-VP
O	124	131	protein	protein	NN	B-NP
O	131	132	,	,	,	O
O	133	139	acidic	acidic	JJ	B-ADJP
O	140	143	and	and	CC	I-ADJP
O	144	148	rich	rich	JJ	I-ADJP
O	149	151	in	in	IN	B-PP
O	152	160	cysteine	cysteine	NN	B-NP
O	160	161	)	)	)	O
O	162	164	is	be	VBZ	B-VP
O	165	172	closely	closely	RB	B-ADJP
O	173	180	related	related	JJ	I-ADJP
O	181	185	with	with	IN	B-PP
O	186	189	the	the	DT	B-NP
O	190	198	progress	progress	NN	I-NP
O	198	199	,	,	,	I-NP
O	200	208	invasion	invasion	NN	I-NP
O	209	212	and	and	CC	I-NP
O	213	223	metastasis	metastasis	NN	I-NP
O	224	226	of	of	IN	B-PP
B-Cancer	227	236	malignant	malignant	JJ	B-NP
I-Cancer	237	242	tumor	tumor	NN	I-NP
O	243	246	and	and	CC	I-NP
O	247	259	angiogenesis	angiogenesis	NN	I-NP
O	259	260	.	.	.	O

O	261	268	METHODS	METHODS	NNS	B-NP
O	268	269	:	:	:	O
O	270	275	Using	Use	VBG	B-VP
O	276	281	human	human	JJ	B-NP
B-Tissue	282	287	colon	colon	NN	I-NP
I-Tissue	288	302	adenocarcinoma	adenocarcinoma	NN	I-NP
I-Tissue	303	310	tissues	tissue	NNS	I-NP
O	311	312	(	(	(	O
O	312	323	hereinafter	hereinafter	RB	B-VP
O	324	332	referred	refer	VBN	I-VP
O	333	335	to	to	TO	B-PP
O	336	338	as	as	IN	B-SBAR
B-Cancer	339	344	colon	colon	NN	B-NP
I-Cancer	345	351	cancer	cancer	NN	I-NP
O	351	352	)	)	)	O
O	353	356	and	and	CC	O
O	357	362	their	their	PRP$	B-NP
O	363	376	corresponding	correspond	VBG	I-NP
B-Tissue	377	380	non	non	AFX	B-NP
I-Tissue	380	381	-	-	HYPH	I-NP
I-Tissue	381	389	diseased	diseased	JJ	B-NP
I-Tissue	390	395	colon	colon	NN	I-NP
O	396	400	from	from	IN	B-PP
O	401	404	114	114	CD	B-NP
O	405	413	patients	patient	NNS	I-NP
O	413	414	'	'	POS	B-NP
B-Tissue	415	423	biopsies	biopsy	NNS	I-NP
O	423	424	,	,	,	O
O	425	428	the	the	DT	B-NP
O	429	439	expression	expression	NN	I-NP
O	440	442	of	of	IN	B-PP
O	443	448	SPARC	SPARC	NN	B-NP
O	449	452	and	and	CC	O
O	453	461	vascular	vascular	JJ	B-NP
O	462	473	endothelial	endothelial	JJ	I-NP
O	474	480	growth	growth	NN	I-NP
O	481	487	factor	factor	NN	I-NP
O	488	489	(	(	(	O
O	489	493	VEGF	VEGF	NN	B-NP
O	493	494	)	)	)	O
O	495	499	were	be	VBD	B-VP
O	500	512	investigated	investigate	VBN	I-VP
O	513	515	by	by	IN	B-PP
O	516	536	immunohistochemistry	immunohistochemistry	NN	B-NP
O	537	545	staining	staining	NN	I-NP
O	546	548	to	to	TO	B-VP
O	549	559	assessment	assessment	VB	I-VP
O	560	563	the	the	DT	B-NP
O	564	576	relationship	relationship	NN	I-NP
O	577	584	between	between	IN	B-PP
O	585	590	SPARC	SPARC	NN	B-NP
O	591	594	and	and	CC	I-NP
O	595	599	VEGF	VEGF	NN	I-NP
O	599	600	,	,	,	O
O	601	603	as	as	RB	B-CONJP
O	604	608	well	well	RB	I-CONJP
O	609	611	as	as	IN	I-CONJP
O	612	617	their	their	PRP$	B-NP
O	618	628	prognostic	prognostic	JJ	I-NP
O	629	641	significance	significance	NN	I-NP
O	642	644	in	in	IN	B-PP
O	645	653	patients	patient	NNS	B-NP
O	653	654	.	.	.	O

O	655	665	Evaluation	Evaluation	NN	B-NP
O	666	668	of	of	IN	B-PP
O	669	673	VEGF	VEGF	NN	B-NP
O	674	684	expression	expression	NN	I-NP
O	685	690	level	level	NN	I-NP
O	691	695	with	with	IN	B-PP
O	696	699	the	the	DT	B-NP
O	700	704	same	same	JJ	I-NP
B-Tissue	705	712	tissues	tissue	NNS	I-NP
O	713	716	was	be	VBD	B-VP
O	717	721	used	use	VBN	I-VP
O	722	724	to	to	TO	B-VP
O	725	734	establish	establish	VB	I-VP
O	735	738	the	the	DT	B-NP
O	739	748	antigenic	antigenic	JJ	I-NP
O	749	757	profiles	profile	NNS	I-NP
O	757	758	,	,	,	O
O	759	762	and	and	CC	O
O	763	766	the	the	DT	B-NP
O	767	773	marker	marker	NN	I-NP
O	774	776	of	of	IN	B-PP
O	777	781	CD34	CD34	NN	B-NP
O	782	790	staining	staining	NN	I-NP
O	791	794	was	be	VBD	B-VP
O	795	799	used	use	VBN	I-VP
O	800	802	as	as	IN	B-PP
O	803	805	an	an	DT	B-NP
O	806	815	indicator	indicator	NN	I-NP
O	816	818	of	of	IN	B-PP
B-Tissue	819	830	microvessel	microvessel	NN	B-NP
O	831	838	density	density	NN	I-NP
O	839	840	(	(	(	O
O	840	843	MVD	MVD	NN	B-NP
O	843	844	)	)	)	O
O	844	845	.	.	.	O

O	846	853	RESULTS	RESULTS	NNS	B-NP
O	853	854	:	:	:	O
O	855	860	SPARC	SPARC	NN	B-NP
O	861	871	expression	expression	NN	I-NP
O	872	875	was	be	VBD	B-VP
O	876	882	mainly	mainly	RB	B-ADVP
O	883	885	in	in	IN	B-PP
O	886	889	the	the	DT	B-NP
B-Cell	890	897	stromal	stromal	JJ	I-NP
I-Cell	898	903	cells	cell	NNS	I-NP
O	904	915	surrounding	surround	VBG	B-VP
O	916	919	the	the	DT	B-NP
B-Cancer	920	925	colon	colon	NN	I-NP
I-Cancer	926	932	cancer	cancer	NN	I-NP
O	932	933	,	,	,	O
O	934	937	and	and	CC	O
O	938	941	was	be	VBD	B-VP
O	942	953	significant	significant	JJ	B-NP
O	954	964	difference	difference	NN	I-NP
O	965	967	in	in	IN	B-PP
O	968	973	those	those	DT	B-NP
B-Tissue	974	981	tissues	tissue	NNS	I-NP
O	982	986	with	with	IN	B-PP
O	987	990	the	the	DT	B-NP
B-Multi-tissue_structure	991	996	lymph	lymph	NN	I-NP
I-Multi-tissue_structure	997	1001	node	node	NN	I-NP
O	1002	1012	metastasis	metastasis	NN	I-NP
O	1013	1016	and	and	CC	O
O	1017	1032	differentiation	differentiation	NN	B-NP
O	1033	1039	degree	degree	NN	I-NP
O	1040	1042	of	of	IN	B-PP
B-Cancer	1043	1048	tumor	tumor	NN	B-NP
O	1048	1049	.	.	.	O

O	1050	1060	Expression	Expression	NN	B-NP
O	1061	1063	of	of	IN	B-PP
O	1064	1069	SPARC	SPARC	NN	B-NP
O	1070	1073	was	be	VBD	B-VP
O	1074	1087	significantly	significantly	RB	I-VP
O	1088	1098	correlated	correlate	VBN	I-VP
O	1099	1103	with	with	IN	B-PP
O	1104	1107	the	the	DT	B-NP
O	1108	1118	expression	expression	NN	I-NP
O	1119	1121	of	of	IN	B-PP
O	1122	1126	VEGF	VEGF	NN	B-NP
O	1127	1130	and	and	CC	I-NP
O	1131	1134	MVD	MVD	NN	I-NP
O	1135	1137	in	in	IN	B-PP
B-Tissue	1138	1143	colon	colon	NN	B-NP
I-Tissue	1144	1150	cancer	cancer	NN	I-NP
I-Tissue	1151	1158	tissues	tissue	NNS	I-NP
O	1158	1159	.	.	.	O

O	1160	1168	Patients	Patient	NNS	B-NP
O	1169	1173	with	with	IN	B-PP
O	1174	1177	low	low	JJ	B-NP
O	1178	1180	or	or	CC	I-NP
O	1181	1188	absence	absence	NN	I-NP
O	1189	1199	expressing	express	VBG	I-NP
O	1200	1205	SPARC	SPARC	NN	I-NP
O	1206	1209	had	have	VBD	B-VP
O	1210	1223	significantly	significantly	RB	B-NP
O	1224	1229	worse	worse	JJR	I-NP
O	1230	1237	overall	overall	JJ	I-NP
O	1238	1246	survival	survival	NN	I-NP
O	1247	1250	and	and	CC	I-NP
O	1251	1258	disease	disease	NN	I-NP
O	1258	1259	-	-	HYPH	B-NP
O	1259	1263	free	free	JJ	I-NP
O	1264	1272	survival	survival	NN	I-NP
O	1273	1275	in	in	IN	B-PP
O	1276	1277	a	a	DT	B-NP
O	1278	1284	Single	Single	JJ	I-NP
O	1285	1291	Factor	Factor	NN	I-NP
O	1292	1300	Analysis	Analysis	NN	I-NP
O	1300	1301	;	;	:	O
O	1302	1305	Cox	Cox	NNP	B-NP
O	1306	1316	Regression	Regression	NNP	I-NP
O	1317	1325	Analysis	Analysis	NN	I-NP
O	1325	1326	,	,	,	O
O	1327	1332	SPARC	SPARC	NN	B-NP
O	1333	1340	emerged	emerge	VBD	B-VP
O	1341	1343	as	as	IN	B-PP
O	1344	1346	an	an	DT	B-NP
O	1347	1354	overall	overall	JJ	I-NP
O	1355	1363	survival	survival	NN	I-NP
O	1364	1367	and	and	CC	I-NP
O	1368	1375	disease	disease	NN	I-NP
O	1375	1376	-	-	HYPH	B-NP
O	1376	1380	free	free	JJ	I-NP
O	1381	1389	survival	survival	NN	I-NP
O	1390	1401	independent	independent	JJ	I-NP
O	1402	1412	prognostic	prognostic	JJ	I-NP
O	1413	1419	factor	factor	NN	I-NP
O	1420	1423	for	for	IN	B-PP
B-Cancer	1424	1429	colon	colon	NN	B-NP
I-Cancer	1430	1436	cancer	cancer	NN	I-NP
O	1436	1437	.	.	.	O

O	1438	1448	CONCLUSION	CONCLUSION	NN	B-NP
O	1448	1449	:	:	:	O
O	1450	1453	The	The	DT	B-NP
O	1454	1457	low	low	JJ	I-NP
O	1458	1468	expression	expression	NN	I-NP
O	1469	1471	or	or	CC	I-NP
O	1472	1479	absence	absence	NN	I-NP
O	1480	1482	of	of	IN	B-PP
B-Cell	1483	1490	stromal	stromal	JJ	B-NP
O	1491	1496	SPARC	SPARC	NN	I-NP
O	1497	1500	was	be	VBD	B-VP
O	1501	1503	an	an	DT	B-NP
O	1504	1515	independent	independent	JJ	I-NP
O	1516	1526	prognostic	prognostic	JJ	I-NP
O	1527	1533	factor	factor	NN	I-NP
O	1534	1537	for	for	IN	B-PP
O	1538	1542	poor	poor	JJ	B-NP
O	1543	1552	prognosis	prognosis	NN	I-NP
O	1553	1555	of	of	IN	B-PP
B-Cancer	1556	1561	colon	colon	NN	B-NP
I-Cancer	1562	1568	cancer	cancer	NN	I-NP
O	1568	1569	.	.	.	O

O	1570	1575	SPARC	SPARC	NN	B-NP
O	1576	1581	maybe	maybe	RB	B-VP
O	1582	1590	involved	involve	VBN	I-VP
O	1591	1593	in	in	IN	B-PP
O	1594	1597	the	the	DT	B-NP
O	1598	1608	regulation	regulation	NN	I-NP
O	1609	1611	of	of	IN	B-PP
O	1612	1616	anti	anti	AFX	B-NP
O	1616	1617	-	-	HYPH	I-NP
O	1617	1629	angiogenesis	angiogenesis	NN	I-NP
O	1630	1632	by	by	IN	B-PP
O	1633	1638	which	which	WDT	B-NP
O	1639	1641	it	it	PRP	B-NP
O	1642	1645	may	may	MD	B-VP
O	1646	1651	serve	serve	VB	I-VP
O	1652	1654	as	as	IN	B-PP
O	1655	1656	a	a	DT	B-NP
O	1657	1662	novel	novel	JJ	I-NP
O	1663	1669	target	target	NN	I-NP
O	1670	1673	for	for	IN	B-PP
B-Cancer	1674	1679	colon	colon	NN	B-NP
I-Cancer	1680	1686	cancer	cancer	NN	I-NP
O	1687	1696	treatment	treatment	NN	I-NP
O	1697	1699	as	as	RB	B-CONJP
O	1700	1704	well	well	RB	I-CONJP
O	1705	1707	as	as	IN	I-CONJP
O	1708	1709	a	a	DT	B-NP
O	1710	1715	novel	novel	JJ	I-NP
O	1716	1727	distinctive	distinctive	JJ	I-NP
O	1728	1734	marker	marker	NN	I-NP
O	1734	1735	.	.	.	O

